Literature DB >> 35236807

Importance to Know the Long-Term Outcome after Endovascular Therapy with Bare Metal Stent Implantation for Femoropopliteal Artery Disease.

Naruhiko Ito1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35236807      PMCID： PMC9529404          DOI： 10.5551/jat.ED194

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.394


× No keyword cloud information.
  10 in total

1.  Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.

Authors:  John R Laird; Peter A Schneider; Gunnar Tepe; Marianne Brodmann; Thomas Zeller; Christopher Metzger; Prakash Krishnan; Dierk Scheinert; Antonio Micari; David J Cohen; Hong Wang; Melissa S Hasenbank; Michael R Jaff
Journal:  J Am Coll Cardiol       Date:  2015-10-14       Impact factor: 24.094

2.  A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.

Authors:  William A Gray; Koen Keirse; Yoshimitsu Soga; Andrew Benko; Anvar Babaev; Yoshiaki Yokoi; Henrik Schroeder; Jeffery T Prem; Andrew Holden; Jeffrey Popma; Michael R Jaff; Juan Diaz-Cartelle; Stefan Müller-Hülsbeck
Journal:  Lancet       Date:  2018-09-24       Impact factor: 79.321

3.  1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon.

Authors:  Ravish Sachar; Yoshimitsu Soga; Mohammad M Ansari; Amane Kozuki; Louis Lopez; Marianne Brodmann; Herman Schroë; Vijay S Ramanath; Juan Diaz-Cartelle; Thomas Zeller
Journal:  JACC Cardiovasc Interv       Date:  2021-05-24       Impact factor: 11.195

4.  Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.

Authors:  Kenneth Rosenfield; Michael R Jaff; Christopher J White; Krishna Rocha-Singh; Carlos Mena-Hurtado; D Christopher Metzger; Marianne Brodmann; Ernst Pilger; Thomas Zeller; Prakash Krishnan; Roger Gammon; Stefan Müller-Hülsbeck; Mark R Nehler; James F Benenati; Dierk Scheinert
Journal:  N Engl J Med       Date:  2015-06-24       Impact factor: 91.245

5.  Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease.

Authors:  Yoshimitsu Soga; Mitsuyoshi Takahara; Osamu Iida; Kenji Suzuki; Shinsuke Mori; Daizo Kawasaki; Kazuki Haraguchi; Terutoshi Yamaoka; Kenji Ando
Journal:  J Atheroscler Thromb       Date:  2021-12-14       Impact factor: 4.394

6.  Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.

Authors:  Takeshi Tada; Kazushige Kadota; Shingo Hosogi; Koshi Miyake; Masanobu Ohya; Hideo Amano; Yu Izawa; Takenori Kanazawa; Shunsuke Kubo; Tahei Ichinohe; Yusuke Hyoudou; Yuki Hayakawa; Mahmoud Mohamed Hassan Sabbah; Suguru Otsuru; Daiji Hasegawa; Seiji Habara; Hiroyuki Tanaka; Yasushi Fuku; Harumi Katoh; Tsuyoshi Goto; Kazuaki Mitsudo
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-09       Impact factor: 6.875

7.  Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.

Authors:  Hans Krankenberg; Thilo Tübler; Maja Ingwersen; Michael Schlüter; Dierk Scheinert; Erwin Blessing; Sebastian Sixt; Arne Kieback; Ulrich Beschorner; Thomas Zeller
Journal:  Circulation       Date:  2015-10-07       Impact factor: 29.690

8.  Pathology and Multimodality Imaging of Acute and Chronic Femoral Stenting in Humans.

Authors:  Salomé H Kuntz; Sho Torii; Hiroyuki Jinnouchi; Anne Cornelissen; Atsushi Sakamoto; Yu Sato; Matthew Kutyna; Maria E Romero; Anne Lejay; Adeline Schwein; Emilie Bonnin; Aloke V Finn; Nabil Chakfé; Renu Virmani
Journal:  JACC Cardiovasc Interv       Date:  2020-02-24       Impact factor: 11.195

9.  Angiographic flow velocity predicts lower limb outcomes after endovascular therapy: Application of the frame count method.

Authors:  Naruhiko Ito; Keiichi Hishikari; Hiroshi Yoshikawa; Shihoko Tsujihata; Fumiyuki Abe; Yoshinori Kanno; Munehiro Iiya; Tadashi Murai; Hiroyuki Hikita; Atsushi Takahashi; Taishi Yonetsu; Tetsuo Sasano
Journal:  Vasc Med       Date:  2021-07-21       Impact factor: 3.239

10.  Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.

Authors:  Michael D Dake; Gary M Ansel; Michael R Jaff; Takao Ohki; Richard R Saxon; H Bob Smouse; Lindsay S Machan; Scott A Snyder; Erin E O'Leary; Anthony O Ragheb; Thomas Zeller
Journal:  Circulation       Date:  2016-03-11       Impact factor: 29.690
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.